Mersana Therapeutics is a biopharmaceutical organization that specializes in the discovery and development of antibody-drug conjugate (ADC) therapies to treat patients battling cancer. Utilizing many years of industrial learning, they have created restrictive and profoundly distinctive ADC platforms and abilities to quickly plan and test novel ADCs and recognize those with ideal viability, security, and tolerability. Utilizing this methodology, they are building a vigorous pipeline of ADC professionals with the possibility to have a daily routine changing effect for individuals experiencing cancer. Their accomplished supervisory group shares a solid obligation to logical greatness and patient consideration, hence developing a profoundly communitarian and inviting work environment. At Mersana, they have an enthusiasm for propelling treatments that have a huge effect on the existence of individuals living with the disease, and for this, they are paid nicely by the company.
Similar companies
